<SEC-DOCUMENT>0001615774-17-005170-index.html : 20170918
<SEC-HEADER>0001615774-17-005170.hdr.sgml : 20170918
<ACCEPTANCE-DATETIME>20170918211319
ACCESSION NUMBER:		0001615774-17-005170
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170918
FILED AS OF DATE:		20170918
DATE AS OF CHANGE:		20170918

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Vivo Capital VIII, LLC
		CENTRAL INDEX KEY:			0001618789
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		171091005

	BUSINESS ADDRESS:	
		STREET 1:		505 HAMILTON AVENUE, SUITE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301
		BUSINESS PHONE:		650 688 0822

	MAIL ADDRESS:	
		STREET 1:		505 HAMILTON AVENUE, SUITE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics plc
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		56 FITZWILLIAM SQUARE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		(610) 816-6640

	MAIL ADDRESS:	
		STREET 1:		1000 CONTINENTAL DRIVE
		STREET 2:		SUITE 600
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nabriva Therapeutics AG
		DATE OF NAME CHANGE:	20150507
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>s107542_f4.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: s107542_f4.html

Document 1 - RAW XML: s107542_f4.xml

</DOCUMENT>
</SEC-DOCUMENT>